Unmet Needs and Receipt of Supportive Care Services in Head and Neck Cancer Patients Prior to Oncologic Treatment: A Prospective,Cross-Sectional Pilot Study
Restricted accessResearch articleFirst published online November, 2023
Unmet Needs and Receipt of Supportive Care Services in Head and Neck Cancer Patients Prior to Oncologic Treatment: A Prospective,Cross-Sectional Pilot Study
To characterize the supportive care (SC) needs and receipt of SC services among head and neck cancer (HNC) patients prior to oncologic treatment and to explore the influence of social determinants of health on these outcomes.
Materials and Methods:
Newly diagnosed HNC patients were surveyed via telephone prior to oncologic treatment between 10/2019 and 1/2021 using a prospective, cross-sectional, bi-institutional, pilot study design. The primary study outcome was unmet SC needs (Supportive Care Needs Survey-Short Form34 [SCNS-SF34]). Hospital type (university- vs county safety-net) was explored as an exposure. Descriptive statistics were performed using STATA16 (College Station, TX).
Results:
Among 158 potentially eligible patients, 129 were successfully contacted, 78 met the study criteria, and 50 completed the survey. The mean age was 61, 58% exhibited clinical stage III-IV disease, and 68% and 32% were treated at the university and county safety-net hospital, respectively. Patients were surveyed a median of 20 days after their first oncology visit and 17 days prior to initiation of oncology treatment. They had a median of 24 total needs (11 were met and 13 were unmet) and preferred to see a median of 4 SC services but received care from none. County safety-net patients had comparatively more unmet needs than university patients (14.5 vs 11.5, P = .04).
Conclusion:
Pretreatment HNC patients at a bi-institutional academic medical center report a high number of unmet SC needs with corollary poor receipt of available SC services. Novel interventions to address this significant gap in care are needed.
SiegelRLMillerKDFuchsHEJemalA.Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33.
2.
BurrisJLStudtsJLDeRosaAPOstroffJS.Systematic review of tobacco use after lung or head/neck cancer diagnosis: results and recommendations for future research. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1450-1461.
3.
OstroffJSJacobsenPBMoadelAB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75(2):569-576.
4.
ChanYIrishJCWoodSJ, et al. Smoking cessation in patients diagnosed with head and neck cancer. J Otolaryngol. 2004;33(2):75-81.
5.
LydiattWMMoranJBurkeWJ.A review of depression in the head and neck cancer patient. Clin Adv Hematol Oncol. 2009;7(6):397-403.
6.
MisonoSWeissNSFannJRRedmanMYuehB.Incidence of suicide in persons with cancer. J Clin Oncol. 2008;26(29):4731-4738.
7.
DuffySARonisDLValensteinM, et al. Depressive symptoms, smoking, drinking, and quality of life among head and neck cancer patients. Psychosomatics. 2007;48(2):142-148.
8.
GiulianiMMcQuestionMJonesJ, et al. Prevalence and nature of survivorship needs in patients with head and neck cancer. Head Neck. 2016;38(7):1097-1103.
9.
O’BrienKMTimmonsAButowP, et al. Associations between neighbourhood support and financial burden with unmet needs of head and neck cancer survivors. Oral Oncol. 2017;65:57-64.
10.
WellsMCunninghamMLangH, et al. Distress, concerns and unmet needs in survivors of head and neck cancer: a cross-sectional survey. Eur J Cancer Care. 2015;24(5):748-760.
11.
KrebberAMJansenFCuijpersPLeemansCRVerdonck-de LeeuwIM.Screening for psychological distress in follow-up care to identify head and neck cancer patients with untreated distress. Supp Care Cancer. 2016;24(6):2541-2548.
12.
GhazaliNRoeBLoweD, et al. Screening for distress using the distress thermometer and the University of Washington quality of life in post-treatment head and neck cancer survivors. Eur Arch Otorhinolaryngol. 2017;274(5):2253-2260.
13.
Druesne-PecolloNKeitaYTouvierM, et al. Alcohol drinking and second primary cancer risk in patients with upper aerodigestive tract cancers: a systematic review and meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2014;23(2):324-331.
14.
ChenAMDalyMEVazquezE, et al. Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Head Neck Surg. 2013;139(9):885-889.
15.
NinuMBMiccinesiGBulliF, et al. Psychological distress and health-related quality of life among head and neck cancer patients during the first year after treatment. Tumori. 2016;102(1):96-102.
16.
PinquartMDubersteinPR.Depression and cancer mortality: a meta-analysis. Psychol Med. 2010;40(11):1797-1810.
17.
SatinJRLindenWPhillipsMJ.Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer. 2009;115(22):5349-5361.
18.
DeleyiannisFWThomasDBVaughanTLDavisS.Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst. 1996;88(8):542-549.
19.
DuffySARonisDLMcLeanS, et al. Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma. J Clin Oncol. 2009;27(12):1969-1975.
20.
LahartIMMetsiosGSNevillAMCarmichaelAR.Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54(5):635-654.
21.
MishraSISchererRWSnyderCGeiglePMBerlansteinDRTopalogluO.Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev. 2012;2012(8):Cd008465.
22.
CollinsKPGellerDAAntoniM, et al. Sleep duration is associated with survival in advanced cancer patients. Sleep Med. 2017;32:208-212.
23.
PaleshOAldridge-GerryAZeitzerJM, et al. Actigraphy-measured sleep disruption as a predictor of survival among women with advanced breast cancer. Sleep. 2014;37(5):837-842.
24.
NaghaviAOEchevarriaMIStromTJ, et al. Treatment delays, race, and outcomes in head and neck cancer. Cancer Epidemiol. 2016;45:18-25.
25.
NicholsACBhattacharyyaN.Racial differences in stage and survival in head and neck squamous cell carcinoma. Laryngoscope. 2007;117(5):770-775.
26.
ChoiSHTerrellJEFowlerKE, et al. Socioeconomic and other demographic disparities predicting survival among head and neck cancer patients. PLoS One. 2016;11(3):e0149886.
27.
CareyRMParasherAKWorkmanAD, et al. Disparities in sinonasal squamous cell carcinoma short- and long-term outcomes: analysis from the national cancer database. Laryngoscope. 2018;128(3):560-567.
28.
MolinaMACheungMCPerezEA, et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer: an examination of 20,915 patients. Cancer. 2008;113(10):2797-2806.
29.
HalpernMTWardEMPavluckALSchragNMBianJChenAY.Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9(3):222-231.
30.
InversoGMahalBAAizerAADonoffRBChuangSK.Health insurance affects head and neck cancer treatment patterns and outcomes. J Oral Maxillofac Surg. 2016;74(6):1241-1247.
31.
KwokJLangevinSMArgirisAGrandisJRGoodingWETaioliE.The impact of health insurance status on the survival of patients with head and neck cancer. Cancer. 2010;116(2):476-485.
32.
NaghaviAOEchevarriaMIGrassGD, et al. Having medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016;122(22):3529-3537.
33.
ShinJYYoonJKShinAKBlumenfeldPMaiMDiazAZ.Association of insurance and community-level socioeconomic status with treatment and outcome of squamous cell carcinoma of the pharynx. JAMA Otolaryngol Head Neck Surg. 2017;143(9):899-907.
34.
HarrisPATaylorRThielkeRPayneJGonzalezNCondeJG.Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
35.
HarrisPATaylorRMinorBL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.
ScholzUGutiérrez DoñaBSudSSchwarzerR.Is general self-efficacy a universal construct?1. Eur J Psychol Assess. 2002;18(3):242-251.
38.
NewellSASanson-FisherRWSavolainenNJ.Systematic review of psychological therapies for cancer patients: overview and recommendations for future research. J Natl Cancer Inst. 2002;94(8):558-584.
39.
StantonAL.Psychosocial concerns and interventions for cancer survivors. J Clin Oncol. 2006;24(32):5132-5137.
40.
RibaMDonovanKAndersenB, et al. Distress management, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(10):1229-1249.
41.
GraboyesEMKompelliARNeskeyDM, et al. Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145(2):166-177.
42.
MurphyCTGallowayTJHandorfEA, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169-178.
43.
RygalskiCJZhaoSEskanderA, et al. Time to surgery and survival in head and neck cancer. Ann Surg Oncol. 2021;28(2):877-885.
44.
WindonMJD’SouzaGFarajiF, et al. Priorities, concerns, and regret among patients with head and neck cancer. Cancer. 2019;125(8):1281-1289.
45.
FagerlindHKettis GlimeliusBRingL.Barriers against psychosocial communication: oncologists' perceptions. Clin Oncol. 2013;31(30):3815-3822.
46.
LuckettTDavidsonPMBoyleF, et al. Australian survey of current practice and guideline use in adult cancer pain assessment and management: perspectives of oncologists. Asia Pac J Clin Oncol. 2014;10(2):e99-107.
47.
BerkowitzCAllenDHTenhoverJ, et al. Knowledge and preferences of primary care providers in delivering head and neck cancer survivorship care. J Cancer Educ. 2018;33(6):1323-1327.
48.
ChenSCYuPJHongMY, et al. Communication dysfunction, body image, and symptom severity in postoperative head and neck cancer patients: factors associated with the amount of speaking after treatment. Support Care Cancer. 2015;23(8):2375-2382.
49.
ProutyCDMazorKMGreeneSM, et al. Providers' perceptions of communication breakdowns in cancer care. J Gen Intern Med. 2014;29(8):1122-1130.
50.
WarrenGWMarshallJRCummingsKM, et al. Addressing tobacco use in patients with cancer: a survey of American society of clinical oncology members. J Oncol Pract. 2013;9(5):258-262.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
